logo
  

Big Lots Guides Q3 EPS Well Above Estimates - Quick Facts

Discount retailer Big Lots, Inc. (BIG) provided on Tuesday the expected results for the third quarter of fiscal 2020. The company estimates comparable sales will increase in the mid-teens for the quarter.

Based on this sales outlook, the company estimates it will generate earnings in a range of $0.50 to $0.70 per share for the third quarter. This guidance incorporates expected share repurchase activity for the quarter.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.21 per share for the quarter. Analysts' estimates typically exclude special items.

The company said a month ago that it is not in a position to re-instate its financial guidance for the full-year 2020 as it continues to believe it does not have sufficient visibility amidst the ongoing COVID-19 pandemic. It had withdrawn its financial guidance for the first quarter and full year 2020 in late March.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
RELATED NEWS
Follow RTT